| Unique Identifier | RID10108 |
| Reference | Experiment Type | Cell/Tissue/Microbe/Strain | Test Organism | Lifestage | Administration Method | Target Organism | Administered Dose Range | Significant Dose Range | Time to Death of Pathogen (min) | Anthelminthic Efficacy (%) | Therapeutic Action |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PMID:23825733 | In vitro | ATCC 23715 | - | - | - | Yersinia enterocolitica | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial |
| In vitro | - | Clarias gariepinus | - | - | Edwardsiella tarda | 0.488-0.977 μg/mL |
0.488-0.977 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Edwardsiella spp. | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Escherichia coli | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Salmonella spp. | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Streptococcus spp. | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Vibrio damsela | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Aeromonas spp. | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Edwardsiella spp. | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Escherichia coli | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Pseudomonas spp. | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Salmonella spp. | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Vibrio spp. | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Penaeus monodon | - | - | Vibrio spp. | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Monopterus albus | - | - | Edwardsiella tarda | 0.244-0.488 μg/mL |
0.244-0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC13813 | - | - | - | Streptococcus agalactiae | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Penaeus vannamei | - | - | Vibrio spp. | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Rana catesbeiana | - | - | Aeromonas spp. | 0.977 μg/mL |
0.977 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Rana catesbeiana | - | - | Edwardsiella spp. | 0.977 μg/mL |
0.977 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Rana catesbeiana | - | - | Flavobacterium spp. | 0.977 μg/mL |
0.977 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Rana catesbeiana | - | - | Vibrio spp. | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Scylla sp. | - | - | Vibrio spp. | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Tilapia sp. | - | - | Edwardsiella tarda | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 15947 | - | - | - | Edwardsiella tarda | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 25922 | - | - | - | Escherichia coli | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 35032 | - | - | - | Pseudomonas aeruginosa | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 49140 | - | - | - | Aeromonas hydrophila | 0.488 μg/mL |
0.488 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 8090 | - | - | - | Citrobacter freundii | 0.244 μg/mL |
0.244 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Trichogaster pectoralis | - | - | Edwardsiella tarda | 0.244-0.488 μg/mL |
0.244-0.488 μg/mL |
- | - | Antibacterial |
ReCAnt is a database of chemicals used in aquaculture and their ecotoxic effects, compiled from published literature. The authors are not liable for any inaccuracies or omissions of any chemicals in this resource. Importantly, our sole goal to build this resource on chemicals used in aquaculture is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.